2,5-dimethoxy-4-bromoamphetamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 2 |
| Glennon, RA; Lyon, RA; McKenney, JD; Titeler, M | 1 |
| Benington, F; Glennon, RA; Morin, RD; Young, R | 1 |
| Glennon, RA; Lucaites, VL; Nelson, DL; Wainscott, DB | 1 |
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Bondarev, ML; Glennon, RA; Hellberg, MR; Khorana, N; May, JA; McLaughlin, MA; Sharif, NA; Young, R | 1 |
1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
6 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer
| Article | Year |
|---|---|
5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.
Topics: Animals; Anisoles; Binding, Competitive; Generalization, Stimulus; In Vitro Techniques; Male; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Stereoisomerism; Structure-Activity Relationship | 1986 |
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Topics: Amphetamines; Animals; Behavior, Animal; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; In Vitro Techniques; Isomerism; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1982 |
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Topics: Amphetamines; Animals; Cloning, Molecular; Hallucinogens; Humans; Propylamines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Topics: Animals; Antihypertensive Agents; Binding, Competitive; Blood-Brain Barrier; Cerebral Cortex; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Intraocular Pressure; Macaca fascicularis; Male; Ocular Hypertension; Oxygen; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship | 2004 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |